-
LUYE PHARMA Partners with Myung In Pharma on Lisdem Patch for Alzheimer's Disease
In a groundbreaking collaboration, LUYE PHARMA has signed a partnership agreement with Myung In Pharma, a leading South Korean pharmaceutical company,...
2024-02-06 13:49 -
CFO Transition: Innovent Bio Announces Retirement of Chief Financial Officer Xi Hao, Appoints Yu Fei...
In a recent announcement, Innovent Bio, a leading biopharmaceutical company focused on innovative drugs in the fields of oncology, immunology, metabol...
2024-02-06 11:54 -
Takeda Announces Notable Personnel Changes in the Oncology and Finance Departments
Takeda, a leading pharmaceutical company, has recently made significant personnel changes within its organization. In this article, we will discuss tw...
2024-02-06 11:52 -
The Golden Window of Breakthrough Medications: Unveiling NASH's Potential in 2024
In the realm of medical advancements, the year 2024 holds great promise for the breakthrough treatment of Nonalcoholic Steatohepatitis (NASH).
2024-02-06 11:49 -
Breakthrough in Cancer Treatment: SynAffix and Innovent Bio Initiate Phase III Clinical Trial for Cl...
In a significant development in the field of cancer therapeutics, Xinda Biotechnology, in collaboration with SynAffix, has commenced a Phase III clini...
2024-02-05 16:22 -
The Longest Struggle: Unveiling Japan's Stock Market Crisis and Resilience
Japan's stock market crisis in the 1990s remains one of the longest and most impactful economic struggles in modern history.
2024-02-05 16:18 -
The Rise of Co-CEOs in the Pharmaceutical Industry: A Game-Changer or a False Proposition?
In the fast-paced and ever-evolving pharmaceutical industry, the role of a CEO carries immense responsibility. They are often hailed as the face of su...
2024-02-05 16:10 -
Breakthrough Approval in China: Merck's PD-1 Inhibitor, Keytruda®, Granted New Indication for Combi...
In a significant development for cancer treatment, Merck's PD-1 inhibitor, Keytruda® (pembrolizumab), has received approval from the National Medical...
2024-02-05 16:09 -
Chinese CGM Manufacturers Surpass Expectations in Europe Market Competition
In recent years, Chinese Continuous Glucose Monitoring (CGM) manufacturers have made significant strides in the European market, exceeding expectation...
2024-02-05 16:08 -
The Plummet of a Consumer Genetic Testing Pioneer: From $6.5 Billion to Near Zero Market Value
Consumer genetic testing companies, once hailed as the future of personalized healthcare, are facing a harsh reality.
2024-02-04 16:55
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products